News Industry News Bellerophon Reaches Agreement with FDA on Study Design of Phase 2b Trial of INOpulse® for Treatment of Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease May 08, 2018
News Industry News Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research October 27, 2016